Researchers from Lund University in Sweden, Herlev Hospital, Knight Centre and Immunovia AB worked together to develop the blood test that utilises samples from both Denmark and the US at different stages of the disease. Pancreatic cancer is notoriously difficult to detect and diagnose, and as such, it is among the highest causes of cancer
Current WSU research shows stimuli-responsive nanoparticles can specifically target infections to simultaneously prevent the spread of bacteria and reduce the inflammation it causes. These microscopic particles are loaded with antibiotic and anti-inflammatory agents which are released when the particles encounter infection in the body. Researchers in the lab of Pharmaceutical Sciences Assistant Professor Zhenjia Wang
A team led by the Institute of Cancer Research London (ICR) and the University of Edinburgh developed a new technique known as Revolver (Repeated Evolution of Cancer). Which could enable doctors to create the most effective treatment for each patient. The technique picks out patterns in DNA mutation within cancers and then uses the information
